Bioceptive 20iud 20inserter

Bioceptive, Inc.

Bioceptive is a women’s health company developing innovative products to improve care for women all over the world.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location New Orleans, LA, USA
  • Currency USD
  • Founded August 2010
  • Employees 5
  • Website

Company Summary

Bioceptive is a women’s health company developing innovative products to improve care for women worldwide. Bioceptive has developed a patent-pending intrauterine device (IUD) inserter that revolutionizes the IUD insertion field. Currently, 175 million women use IUDs worldwide and it is increasing by 4.6% annually. Bioceptive has its first 510k of a suction based retractor that replaces tenaculum and forms a basis of creating other devices.


  • Default avatar
    Stewart B. Davis, MD
    Chief Executive Officer & President

    Dr. Davis has extensive operational experience working as an executive and/or founder in six medical device start-ups. He has previous experience in gaining FDA and CE Mark clearance for nine devices, has successfully commercialized several of these medical devices, took his last company public and has overseen multiple exits. Additionally, Dr. Davis is experienced in building sales teams and launching full international sales rollouts.

  • Default avatar
    Shuchi P. Khurana
    Chief Operating Officer

    Shuchi "SK" Khurana has fourteen years of experience in various fields including technology commercialization, product management, new product development, business development and marketing. Prior to Bioceptive, he was managing a portfolio of six products and a multi-million dollar R&D program.

    SK holds two masters degrees, MBA and MS from The Ohio State University, and a B.Tech. degree from Indian Institute of Technology (IIT) Kanpur.

  • Default avatar
    Benjamin D. Cappiello
    Chief Scientific Officer

    Benjamin is a biomedical engineer and graduate of Tulane University. He is the inventor of the Bioceptive Inserter.

    Ben has done research in the laboratory of the renowned adult stem cell bioengineer, James L. Sherley, MD, PhD, and wrote his thesis, Analysis and Automation of the Quantification of Asymmetric Self Renewal Kinetics of Human Hepatic Stem Cells, based upon his research there.


  • Default avatar
    Graffagnini and Associates ; Cooley LLP
    Default avatar
    Wegmann Dazet and Company

Previous Investors

  • Default avatar
    First Light Ventures
    Default avatar
    Abstraction Ventures
    Default avatar
    Tamara Kreinin
  • Default avatar
    Calvert Funds